Collaborations

62,540 FTE days completed 2000-2005

Merz "The collaboration with Asinex allowed Merz Pharmaceuticals to select new chemical compounds of interest for its drug discovery programs. The collaboration is progressing with the improvement of physicochemical parameters of new lead compounds that will be tested in our laboratories. We are looking forward to continuing the collaboration with ASINEX all the way through to candidate selection and optimization"

BioVitrum "the shared risk drug discovery collaboration with ASINEX allows Biovitrum to cost-effectively expand its drug discovery project portfolio and increase the delivery of drugs for clinical development."

Recordati "The collaboration with Asinex allowed Recordati to select new chemical structures of interest for its drug discovery programs. The collaboration is now continuing with the synthesis of new lead compounds, that will be tested in our laboratories. We are looking forward to continuing the collaboration with ASINEX all the way through to candidate selection and optimization".

Avalon "We have been very pleased by the quality of work of Asinex chemists and by the contribution they made to a rapid progression of our Lead Optimization programs. It's been a good and productive collaboration and I am happy to see Asinex and Avalon continue working together for another year."

Asahi "This collaboration with ASINEX has been a significant benefit to our research efforts at Asahi Kasei. Through our collaboration we were able to identify a number of new lead compounds of therapeutic interest in a short period of time. We are very happy with the skill and talents of ASINEX's scientists, and believe their cost-effectiveness and reliability puts them well ahead of their competition. Asahi Kasei is looking forward to enjoying a long and fruitful collaboration with ASINEX."